Research
Hormonal
Tirzepatide has been approved by the FDA for type 2 diabetes in adults as a single dose weekly.
Practitioners can prescribe Tirzepatide for managing type 2 diabetes in adults.
StrongSupportsmedium confidence
Tirzepatide, a glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist has recently been approved by FDA for type 2 diabetes in adults as a single dose weekly.
Why this rating
The claim is based on regulatory approval, which is a strong form of evidence.
Source
Tirzepatide: Revolutionary Drug in Management of “Diabesity”
Vansh Chouhan et al. · International Journal of Medical and Dental Sciences · 2022
other
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →